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BACKGROUND: The prelimbic area (PL) of the prefrontal cortex is susceptible to abnormal developmental stimuli that raises the risk 
of addiction. Glutamate receptors play a key role in 
opiate reinforcement and reward functions in this area. 
Therefore, we examined the effect of the DL-2-amino-5-
phosphonopentanoic acid (AP5), as N-methyl-D-aspartate 
(NMDA) receptor antagonist into the PL on the phases of 
conditioned place preference (CPP) induced by morphine.
METHODS: Male Wistar rats were divided into 12 groups 
(3 surgical groups for each dose of morphine in any phase 
of CPP) and anaesthetized with chloral hydrate. Cannula 
was implanted into the PL and the AP5 was injected into 
this area and morphine-induced CPP was investigated. Data 
were processed with the commercially available SPSS 22 
software using one-way ANOVA and Tukey's test. p<0.05 
were considered statistically significant.
RESULTS:  Our findings indicated, morphine in doses of 
2.5 to 10 mg/kg induced CPP. Microinjection of various 
doses of the AP5 into the PL before the administration of 
the effective dose of morphine significantly reduced place 
preference in the acquisition and the expression phases 
of the CPP test compared to the sham group (p<0.001). 
In another set of our experiments was seen that, different 
doses of the AP5 with the ineffective dose of morphine only 
reduced the expression phase of the CPP (p<0.001) while, 
produced neither preference nor aversion effect on the 
acquisition phase (p=0.147).
CONCLUSION:  It seems that the glutamate NMDA 
receptors in the PL through memory formation and 
morphine-related reward signals play a critical role in 
addiction process during morphine-induced CPP.
KEYWORDS: N-methyl-aspartate, morphine, glutamate 
receptor, prefrontal cortex, reward
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Abstract
Introduction
Prelimbic area (PL) is a part of the prefrontal cortex (1) 
that modulates synaptic plasticity differently in nucleus 
accumbens during drug seeking (2). On the other hand, 
scientific evidences have also shown that glutamate 
transmission play a central role in synaptic plasticity.(3) 
The PL  is  also  susceptible  to  abnormal  developmental 
targets that raises the risk for addiction and other psychiatric 
disorders.(4,5) The PL is a section of the reward system 
which role of the glutamate transmission in case of morphine 
addiction in this part of the brain is not entirely clear. Hence, 
a series of behavioral studies were conducted to examine 
the role of the PL glutamate transmission during morphine 
related reward, learning and memory formation.
 The glutamate is one of the most important stimulant 
neurotransmitter in the brain.(6) The glutamate system 
also controls opiate addiction in the PL with the N-methyl-
D-aspartate (NMDA) receptors.(7) NMDA receptor is a 
ligand gated ion channel (8) and one of the fundamental 
neurotransmitter receptors in the brain (9) that is required 
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for activity of dopamine neurons in the ventral tegmental 
area (VTA).(10) The NMDA is a molecular target for 
several abuse drugs.(11) Also, this glutamate receptor plays 
a special role in reward (7), addiction (12) and recalling 
process (13).  So, the current study was designed to evaluate 
the effect of intra-PL microinjection of the  DL-2-amino-
5-phosphonopentanoic acid (AP5) on the effective and the 
ineffective doses of morphine-induced conditioned place 
preference (CPP).
Methods
Animals
Our experiments were performed on male Wistar rats 
(weighing 250-300 g at the beginning of the experiment) 
provided by the Institute of Pasteur, Tehran. Five rats were 
housed per cage, with the room temperature maintaned at 
20-24ºC, under a relative humidity of 40% and 12-hours 
period of light-dark.(14) All experiments were conducted 
in accordance to the international guiding for biomedical 
researches and the committee on animal care which is used 
in Isfahan University of Medical Sciences. All experimental 
protocols were confirmed by the Ethics Committee of 
the Isfahan University of Medical Science, Isfahan, Iran, 
followed the “Principles of Laboratory Animal Care” and 
performed in accordant with the European Communities 
Council Directive of 24 November 1986 (86/609/EEC).
Drug
Morphine was purchased from Temad (Tehran, Iran) and 
AP5 was bought from Sigma (California, USA). Morphine 
and AP5 were dissolved in saline.(14,15) 
Surgical Procedures
Chloral hydrate was used for anaesthetizing of rats (400 
mg/kg, intraperitoneally) then their heads were shaved 
and were located in a stereotaxic device; a cannula (22 
G) was transplanted into the PL (AP=3.2mm, L=0.7mm, 
DV=3mm),  according to the point were defined by Paxinus 
and Watson. (16) Finally, the cannula was anchored in 
the skull by dental cement. In order to preempt infection, 
Gentamycin (40 mg/ml, intraperitoneally) was administered 
immediately following the surgery.
Microinjection Method
All animals were allowed to being recovered for 1 week 
before the beginning of the behavioral test (17,18) and 
they were infused for the CPP experiment, before every 
morphine conditioning session. Animals were tested in a 
morphine-free state.(19)
 Initially, any rat was kept motionless and injection 
needle that was connected to the Hamilton syringe by 
polyethylene tube (PE20) was placed to the guide cannula 
into the PL. The microinjection was done unilaterally via 
lowering  an  injector needle with 1 mm length longer 
than the guide cannula; next, different doses of the AP5 
(0.1µg/0.5µL and 1µg/0.5µL) were injected with rate of 
2 µL/min into the PL, 5 minutes before the acquisition/
expression phases of the experiment.(18) The injection 
cannula was left in the guide  cannula  for  an  additional 
60  second  to  facilitate  diffusion  of  the  drug  and  then 
removed.(15,18,19)  Low or  high  dose  of  the  AP5  was 
microinjected  and  any  rat  was  examined  only  once  for 
behavioral  test  of  the  CPP.
Behavioral Testing-place Preference Paradigm
Among the different behavioral methods were used to 
measure drug reward in laboratory animals, the CPP has 
been one of the most popular. The CPP apparatus consists of 
three chambers (A, B and C). Compartments A and B have 
the same size but different color. The walls inner surface 
and floor of compartment A are black and white while, the 
walls surface and floor of other compartment are all white. 
Compartment C is smaller that opens to parts A and B via a 
guillotine  door.  The  Behavioral  procedure  of  the  CPP 
was done in  five  continuous  days  and  has  three  distinct 
stages.(17,20)
Preconditioning
In the pre-test day, each rat was placed in chamber C while 
the middle door was opened and the rat was allowed move 
freely for 15 minutes in all chambers. The time spent in each 
chamber (A and B) was recorded by the apparatus.
Conditioning
This phase consists of 3 days (from day 2 to day 4 and six 
sessions, 3 saline and 3 morphine), each lasting 45 minutes. 
Guillotine door was closed and the daily injection was 
performed in two stages with a 6 hours interval. After the 
intraperitoneal injection of morphine, the animals were 
confined to morphine compartment of the CPP device for 
45 minuts then, with an interval of 6 hours, following the 
injection of saline instead of morphine, the animals were 
housed to saline compartment of the CPP device for 45 
minuts. On the 3rd day, morphine and saline injections were 
on the contrary to day 2, while on the day 4, morphine and 
saline injections were the same as day 2.(17,20) 
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Post Conditioning
In the post conditioning, after opening the guilltone door, 
animals moved freely in all the compartments of the device 
for 15 minutes. The elapsed time by morphine-recived 
animals in the morphine-paired compartment was recorded. 
The preference was calculated by discrepancy the time 
elapsed in the morphine-paired compartment on the post 
conditioning phase relate to preconditioning phase of the 
CPP paradigm.(17 20) 
Morphine Dose-response on the CPP Paradigm
Different doses of morphine (0.5, 1, 2.5, 5, 7.5 and 10 mg/
kg) were studied on the CPP. Animals were divided into 
7 groups, each group including 7 rats; 6 groups received 
different doses of morphine while one group received saline. 
Morphine or saline was administrated intraperitoneally, 
according to the CPP paradigm and then calculated the 
changes of preference. 
The Effect of the AP5 on Drug-naive and Morphine- 
received Animals
In another set of our experiments, we tested intra-PL AP5 
versus intra-PL saline on three surgical groups of drug-naive 
animals. Also, difference score between intra-PL saline 
versus intra-PL AP5 groups was calculated by assessment 
the amount of time spent in saline-paired environment 
relative to the morphine-paired environment during the 
CPP.(21) 
Microinjection of the AP5 Into the PL with Different 
Doses of Morphine 
According to the experiment design, in this section of our 
experiment 12 groups of rats were used (7 in each group). 
The animals were divided into 3 surgical groups for each 
dose of morphine in any phase of the CPP; sham group 
and test groups (Table 1). Sham group received intra-
PL saline and morphine via intraperitoneally without any 
microinjection of the AP5 but, test groups received intra-
Acquistion Phase Expression Phase
Effective dose
Sham Group
AP5 (0.1µg/0.5µL) group
AP5 (1µg/0.5µL) group
Sham Group
AP5 (0.1µg/0.5µL) group
AP5 (1µg/0.5µL) group
Ineffective dose
Sham Group
AP5 (0.1µg/0.5µL) group
AP5 (1µg/0.5µL) group
Sham Group
AP5 (0.1µg/0.5µL) group
AP5 (1µg/0.5µL) group
CPP Phase
Morphine dose
Table 1. Experimental groups in the CPP test for microinjection 
of the AP5 into the PL with different doses of morphine.
PL low or high doses of the AP5 before administration of 
morphine intraperitoneally on days 2, 3 and 4 during the 
acquisition phase of the CPP paradigm while animals only 
received the AP5 in the post conditioning of the expression 
phase of the CPP protocol.
Histology
After performing behavioral test, the animals were 
anesthetized and were perfused with 0.9% saline followed 
by 10% formalin, rats brains were pulled out carefully and 
were placed in 10% formalin for 72 hours before to being 
sliced.(20) In order to evaluate the place of the antagonist 
injection and cannula, the PL sections were checked 
(Figure 1).
A B
Figure 1. Photograph scan of rat brain's PL. A: Histological 
representation of cannula placement into the PL and site of 
antagonist microinjection in the brain of rat. B: Schematic 
representation of unilateral intra-PL cannula placement.
Statistical Analysis
Our data were analyzed by the commercially available SPSS 
22 software (SPSS Inc, Chicago, IL) using one-way ANOVA 
and Tukey's test. Results are presented as means±s.e.m and 
the difference (with p<0.05) between the experimental 
groups was considered as statistically significant.
Result
Specify of the Effective Dose of Morphine-induced Place 
Preference
Saline and different doses of morphine (0.5, 1, 2.5, 5, 7.5 
and 10 mg/kg) were tested for producing place preference 
in separate groups. Statistical analysis indicated that saline 
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did not induce place preference while, 2.5, 5, 7.5 and 10 
mg/kg doses of morphine had a significant effect (p<0.05, 
p<0.001, p<0.01, p<0.001 respectively) but, 0.5 and 1 mg/
kg doses of morphine did not induce significant effect on 
the CPP (p>0.05). Thus, based on this study 0.5 mg/kg, 
as the ineffective dose and 5 mg/kg, as the effective dose 
of morphine were selected for the subsequent experiment 
(Figure 2).
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on drug-naive animals (p=0.181) (Figure 3A). Statistical 
analysis on difference score from baseline to test sessions 
can  be  performed to determine effects of drug. These 
results showed a significant effect of the AP5 on morphine-
received  animals  while  had  no  effect  on  drug-naive 
animals. 
 Data analysis indicated that difference score 
between intra-PL saline versus intra-PL AP5 groups 
showed a significant effect on time spent in morphine-
paired compartment relative to saline-paired compartment 
(p<0.001) (Figure 3B).
Microinjection of Low-dose AP5 Into the PL with 
Different Doses of Morphine and Its Effect on the 
Acquisition and the Expression Phases of the CPP 
Paradigm
ANOVA analysis showed that the microinjection of low 
dose of the AP5 (0.1μg/0.5μL) into the PL before the 
administration of the effective dose (5mg/kg) of morphine 
significantly decreased the acquisition phase CPP compared 
to the sham group (p<0.001). 
 Based on statistically analysis, the microinjection of 
low-dose AP5 (0.1μg/0.5μL) produced neither preference 
nor aversion effect on the acquisition phase of the CPP 
with the ineffective dose (0.5mg/kg) of morphine (p=0.147) 
(Figure 4A).
 Our results showed that the microinjection of low-dose 
AP5 into the PL before the administration of the effective 
dose of morphine significantly decreased the expression 
phase of the CPP compared to the sham group, also this 
Figure 2. The effect of different doses of morphine on the 
CPP for determining the effective and the ineffective doses of 
morphine. Data was presented at mean±s.e.m and was analyzed 
using one-way ANOVA, Tukey's test. *p<0.05, **p<0.01 and 
***p<0.001 are significant compared to saline group.
Figure 3.  The effect of intra-PL saline or AP5 on drug-naïve animals and morphine-received animals. A: The effect of intra-
PL microinjection different doses of the AP5 in drug-naive animals. B: Difference score between intra-PL saline and intra-PL AP5 in 
morphine-paired compartment relative to saline-paired environments groups. Data was presented at mean±s.e.m and was analyzed using 
one-way ANOVA, Tukey's test.***p<0.001 is significant compared to intra-PL saline group..
The Effect of the AP5 on Drug-naive and Morphine-
received Animals
Our findings showed that, intra-PL microinjection different 
doses of the AP5 versus intra-PL saline produced no effects 
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dose of the AP5 with the ineffective dose of morphine 
induced aversion effect on the expression phase of  the CPP 
(p<0.001) (Figure 4B). 
Microinjection of High-dose AP5 Into the PL with 
Different Doses of Morphine and Its Effect on the 
Acquisition and the Expression Phases of the CPP 
Paradigm
Our results showed that the microinjection of high-dose 
AP5 (1μg/0.5μL) into the PL before the administration 
of the effective dose of morphine (5mg/kg) significantly 
decreased the CPP in the acquisition phase compared to 
the sham group (p<0.001) but, the microinjection of this 
dose into the PL before the administration of the ineffective 
dose of morphine (0.5mg/kg) generated neither preference 
nor aversion effect on the acquisition phase of the CPP 
compared to the sham group, (p=0.314) (Figure 4A).
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Figure 4. The effects of different doses of the AP5 with the 
effective and the ineffective doses of morphine on A: the 
acquisition and B: the expression phases of the CPP paradigm. 
Data was presented at mean±s.e.m and was analyzed using one-
way ANOVA, Tukey's test. ***p<0.001 is significant compared to 
sham group.
Discussion
Our findings showed that place preference increased 
significantly by administration high doses of morphine (2.5, 
5, 7.5 and 10 mg/kg) while low doses of morphine (0.5 and 
1 mg/kg) generated neither preference nor disgust effect 
on the CPP test. The maximum response of the CPP, was 
relevant to dose of 5 mg/kg of morphine. Despite increasing 
dosage of morphine, the dose-response of 7.5 and 10 mg/kg 
of morphine were less than 5 mg/kg, especially 7.5 mg/kg. 
This different response can be related to neuroplasticity and 
adaptation (22) and disorders such as respiratory problems 
(23), nausea and vomiting  (24) and drowsiness  (25) due to 
morphine receiving. Also, it can be related to the response 
of different sections of brain to morphine.(26) Especially 
so, it has been demonstrated that different molecular factors, 
various neuronal pathways and non-rewarding systems are 
involved in this process.(27, 28) Therefore, it seems that 
place preference due to morphine is not dose dependent, 
especially in high doses.
 Previous studies have confirmed these results so that, 
morphine induces rewarding effects which is connected 
to environmental consequences.(17,29) In agreement 
with these results, Kargari et al., and Ghavipanjeh et al., 
reported  that  systemic  administration of morphine 
induced CPP.(17,30) Also, unilateral injection of morphine 
into the nucleus accumbens (NAc) and VTA produced 
CPP in rats.(29) In another set of our experiments, as 
the calculation of difference score showed the effects of 
drug, the microinjection of different doses of the AP5 into 
the PL with  the  effective dose  of morphine  noticeably 
reduced the acquisition and the expression phases of the 
CPP paradigm. To support with these results, previous 
studies indicated that the AP5 attenuates the CPP induced 
by morphine (31) and reduces the response to repeated 
injection of morphine (18). It has been published that, the 
AP5 inhibits the acquisition and the expression phases of 
the CPP that reflect the involvement of the NMDA receptors 
in memory consolidation.(32) Agreement with our finding, 
several studies have highlighted the glutamate NMDA 
 Also, our findings indicated that the microinjection 
of high-dose AP5 (1μg/0.5μL) into the PL before the 
administration of 5 mg/kg or 0.5 mg/kg of morphine 
significantly reversed the effect of morphine on the 
expression phase of the CPP compared to the sham group, 
(p<0.001) (Figure 4B).
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receptor antagonists inhibit the acquisition of morphine-
induced CPP (33) and morphine-rewarding properties.(29)
 Glutamate receptor antagonists disrupt learning and 
memory processes, because the NMDA receptors play 
important roles in regulating the synaptic plasticity.(5) 
Therefore, glutamate antagonists block both the acquisition 
and the expression of morphine induced CPP.(7) Recent 
data have indicated that the activation of glutamatergic 
efferents from the prefrontal cortex to VTA is critical in 
the expression of addictive behaviors (34) and also, similar 
projects to NAc, activate dopamine cells which are essential 
for learning particularly in the acquisition stages.(35) It 
has been found that dopamine-glutamate coactivation is 
neccessary for a number of prefrontal function.(36) One 
probably mechanism is that, the blockade of glutamate 
receptors in the PL disrupts the pathway between the 
prefrontal cortex, VTA and NAc, that probably this disorder 
alters dopaminergic neuronal activities and function of the 
reward system.(37) It seems that euphoria was produced 
by dopamine release, leading to morphine reinforcement. 
Dopamine has an important role in the rewarding pathway 
and it has been clarified that glutamatergic neurons in the 
nucleus accumbens regulate dopamine release. Therefore, 
glutamatergic pathways of NAc have key role on the 
regulation of the mesolimbic dopaminergic system as 
well as such drugs susceptible to abuse as morphine.(33) 
Accordingly, microinjection of glutamate antagonist into 
the PL may alter morphine-related dopaminergic signals 
from the VTA to the NAc, just like that, many of the brain’s 
reward systems converge on the NAc.(38) Evidences have 
been shown that descending projections from prefrontal 
cortex to NAc and other regions of the brain appear to 
exert regulatory control over reward-seeking behavior.(39) 
Therefore addiction is a disregulation between core reward 
system including the PFC, VTA and NAc.(40) 
 In another set of our experiments, results revealed that 
the microinjection of different doses of the AP5 into the PL 
before the administration of the ineffective dose of morphine 
established neither preference nor abhorrence effect on the 
acquisition phase of the CPP. Probably, the glutamate balance 
plays an important role in opiate-conditioned memories.(41) 
Recent findings suggest that memory systems are involved 
in the establishment of drug addiction.(42) On the other 
hand, the interaction between antagonist and balance in 
glutamate homeostasis (41) may alter the level of glutamate 
available for binding to glutamate receptor in the acquisition 
phase of the CPP with the ineffective dose of morphine.(7) 
In our results, it was also found that the microinjection of 
different doses of the AP5 into the PL reversed the effect of 
the morphine-ineffective dose in the expression phase of the 
CPP, which can due to the brain other regions that respond 
to reward systems.(4,21) Probably, the effect of glutamate 
antagonists on the expression phase of the CPP with the 
ineffective dose of morphine can due to synergism effects 
of these agents or the activation of the another neuronal 
pathway.(1) Therefore, the PL of the medial prefrontal 
cortex (mPFC) via glutamatergic system has a critical role 
in morphine-induced CPP. Since, the decrease in morphine-
induced CPP due to the impairment of learning and memory 
formation in the conditioning process that could be reversed 
by physical activities prolonging the long term potentiation 
(LTP) in the neuronal synaptic.(43)
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